The burden of GC varies significantly across regions, with higher incidences in East Asia and an increasing trend among younger populations [ 3 ].
← all excerpts
Overcoming antigen tolerance to develop GB22-45-2, an anti-DKK1 antibody for gastric cancer.
1
—
—